Spiramycin-associated acute dystonia during neuroleptic treatment.
Benazzi
F
F
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced*; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D011618:Psychotic Disorders / Q000188:drug therapy*; D015572:Spiramycin / Q000008:administration & dosage / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D015572:Spiramycin; C011825:fluphenazine depot; D005476:Fluphenazine